CoreMap CEO Sarah Kalil Is Building a Better Way to Treat Atrial Fibrillation | Health Care | Seven Days | Vermont's Independent Voice

Seven Days needs your financial support!

CoreMap CEO Sarah Kalil Is Building a Better Way to Treat Atrial Fibrillation 

Published October 19, 2022 at 10:00 a.m. | Updated October 26, 2022 at 12:55 a.m.

Chelsea Edgar will conduct a live interview with Sarah Kalil and John Abele about their collaboration — and what it takes to turn a great idea into a successful business — during the keynote presentation at the Vermont Tech Jam on Saturday, October 22, 4 p.m., at Hula in Burlington. Talk with other local med-tech companies at the Jam from 10 a.m. to 3:30 p.m. To attend the free event, register at

The original print version of this article was headlined "Tough AF"

Got something to say? Send a letter to the editor and we'll publish your feedback in print!

About The Author

Chelsea Edgar

Chelsea Edgar

Chelsea Edgar is a staff writer for Seven Days, and has written for BuzzFeed and Philadelphia magazine.


Comments are closed.

Since 2014, Seven Days has allowed readers to comment on all stories posted on our website. While we’ve appreciated the suggestions and insights, the time has come to shut them down — at least temporarily.

While we champion free speech, facts are a matter of life and death during the coronavirus pandemic, and right now Seven Days is prioritizing the production of responsible journalism over moderating online debates between readers.

To criticize, correct or praise our reporting, please send us a letter to the editor. Or send us a tip. We’ll check it out and report the results.

Online comments may return when we have better tech tools for managing them. Thanks for reading.

Keep up with us Seven Days a week!

Sign up for our fun and informative

All content © 2022 Da Capo Publishing, Inc. 255 So. Champlain St. Ste. 5, Burlington, VT 05401

Advertising Policy  |  Privacy Policy  |  Contact Us  |  About Us  |  Help
Website powered by Foundation